About
PuriBlood is a medical device company committed to improving the blood filtration and transfusion process with innovative leukoreduction technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)'. In conjunction with RDCMT, we hold over 36+ patents supporting our leukocyte reduction filtration mechanism. From humans to pets, we aim to bring the world a safer solution for transfusion and cell separation. To learn more about PuriBlood, visit www.puriblood.com/index.php
Technologies
Gmail
Outlook
Google Apps
Microsoft Office 365
Amazon AWS
DigitalOcean
Circle
Keywords
blood compatibility
healthcare equipment & supplies
blood component separation
blood filtration membranes
bio-inert surface coating
blood filtration devices
p-tex technology
medical devices
blood compatibility coatings
blood transfusion safety
medical equipment and supplies manufacturing
interpenetrating polymer networks
blood cell separation
leukoreduction
blood filtration research
blood cell capture
blood component processing
cell separation
microbial resistance
microorganism enrichment filters
b2b
zwitterionic materials
anti-biofouling membranes
biocompatible materials
membrane coating
white blood cell removal
biotechnology
blood safety
blood cell adhesion prevention
hemocompatible membranes
Company Information
-
Employees 44
-
Annual Revenue $3370000
Location
Gongye East 9th Road, Hsinchu County, Taiwan, 308
